NCT03484806View on ClinicalTrials.gov

The China Valvular Heart Disease Study

CompletedOBSERVATIONAL
Enrollment

13,917

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

September 1, 2020

Study Completion Date

October 1, 2020

Conditions
Valvular Heart Disease
Trial Locations (1)

100037

Fuwai Hospital, National Center for Cardiovascular Diseases，Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences

OTHER

lead

China National Center for Cardiovascular Diseases

OTHER_GOV

NCT03484806 - The China Valvular Heart Disease Study | Biotech Hunter | Biotech Hunter